HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keitaro Matsuo Selected Research

5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)

10/2008Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
9/2007One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study.
8/2007Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
12/2004Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.
1/2001Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keitaro Matsuo Research Topics

Disease

130Neoplasms (Cancer)
09/2022 - 01/2002
58Breast Neoplasms (Breast Cancer)
09/2022 - 01/2002
44Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2002
35Lung Neoplasms (Lung Cancer)
05/2021 - 04/2002
30Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 10/2004
24Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2002
16Leukemia
01/2021 - 04/2002
15Carcinogenesis
01/2020 - 01/2001
13Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 04/2002
11Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 10/2008
11Infections
01/2020 - 01/2001
11Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 01/2008
10Esophageal Neoplasms (Esophageal Cancer)
02/2022 - 01/2001
10Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 07/2007
10Atrophy
01/2019 - 01/2003
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2018 - 02/2003
9Inflammation (Inflammations)
01/2022 - 04/2003
9Lymphoma (Lymphomas)
08/2019 - 01/2001
9Ovarian Neoplasms (Ovarian Cancer)
02/2018 - 03/2007
9Adenocarcinoma
10/2014 - 09/2007
8Adenocarcinoma of Lung
01/2021 - 05/2002
8Neoplasm Metastasis (Metastasis)
01/2021 - 04/2010
7Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2006
7Colonic Neoplasms (Colon Cancer)
01/2018 - 04/2002
6Flushing
01/2021 - 05/2006
6Philadelphia Chromosome
09/2018 - 02/2008
6Rectal Neoplasms (Rectal Cancer)
01/2018 - 01/2002
6Rheumatoid Arthritis
01/2018 - 09/2005
5Ovarian Epithelial Carcinoma
01/2019 - 07/2014
5Endometrial Neoplasms (Endometrial Cancer)
01/2018 - 03/2007
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 04/2002
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2010 - 05/2008
4Obesity
01/2022 - 05/2010
4Hypertension (High Blood Pressure)
01/2022 - 03/2007
4Urinary Bladder Neoplasms (Bladder Cancer)
07/2020 - 12/2015
4Disease Progression
01/2020 - 01/2007
4Laryngeal Neoplasms (Laryngeal Cancer)
01/2019 - 07/2015
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 08/2003
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 09/2005

Drug/Important Bio-Agent (IBA)

37ORALIT (ORS)IBA
09/2022 - 03/2002
22Biological ProductsIBA
05/2022 - 01/2002
21Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2002
20Estrogen ReceptorsIBA
01/2021 - 10/2002
20ErbB Receptors (EGF Receptor)IBA
06/2017 - 04/2006
19EnzymesIBA
12/2020 - 01/2001
19Folic Acid (Vitamin M)FDA LinkGeneric
07/2016 - 01/2002
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2004
16Aldehyde DehydrogenaseIBA
12/2020 - 01/2001
15Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2011
12Hormones (Hormone)IBA
01/2022 - 01/2002
11CoffeeFDA Link
01/2022 - 03/2007
10AcetaldehydeIBA
07/2020 - 07/2005
9Imatinib Mesylate (Gleevec)FDA Link
09/2018 - 12/2004
9AntigensIBA
01/2018 - 08/2005
9Gefitinib (Iressa)FDA Link
12/2010 - 02/2005
7TeaIBA
01/2022 - 04/2012
7Estrogens (Estrogen)FDA Link
05/2021 - 03/2007
7Fatty Acids (Saturated Fatty Acids)IBA
06/2014 - 01/2005
7Cisplatin (Platino)FDA LinkGeneric
06/2013 - 10/2004
7Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
05/2010 - 04/2004
6Indicators and Reagents (Reagents)IBA
09/2020 - 11/2009
6Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2013
6PlatinumIBA
02/2018 - 05/2009
6Carboplatin (JM8)FDA LinkGeneric
01/2018 - 08/2002
6Tyrosine Kinase InhibitorsIBA
06/2017 - 05/2006
6Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
01/2016 - 05/2006
6Thymidylate SynthaseIBA
05/2010 - 02/2003
5HLA Antigens (Human Leukocyte Antigens)IBA
09/2022 - 04/2005
5Ethanol (Ethyl Alcohol)IBA
01/2022 - 01/2009
5LipidsIBA
01/2022 - 01/2005
5Pepsinogen A (Pepsinogen)IBA
08/2019 - 01/2003
5lysyllysine (Lys-Lys)IBA
01/2019 - 03/2002
5CarbonIBA
10/2008 - 12/2005
55-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA
10/2008 - 01/2001
4HLA-C Antigens (HLA-C)IBA
09/2022 - 03/2007
4SmokeIBA
01/2022 - 02/2003
4AldehydesIBA
01/2021 - 11/2016
4LigandsIBA
05/2019 - 03/2007
4Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 10/2008
4human ERBB2 proteinIBA
01/2019 - 10/2008
4HLA-DRB1 Chains (HLA DRB1)IBA
01/2018 - 12/2011
4glutamyl-glutamic acid (Glu-Glu)IBA
06/2016 - 03/2002
4Carotenoids (Carotene)IBA
01/2016 - 05/2006
4Cyclin-Dependent Kinase Inhibitor p16IBA
01/2016 - 02/2005
4Docetaxel (Taxotere)FDA Link
06/2011 - 07/2002
4Oxidoreductases (Dehydrogenase)IBA
07/2009 - 01/2001
4methionine synthase reductaseIBA
10/2008 - 01/2002
4InterleukinsIBA
04/2003 - 01/2001
3Pharmaceutical PreparationsIBA
01/2022 - 02/2008

Therapy/Procedure

40Drug Therapy (Chemotherapy)
12/2020 - 08/2002
26Therapeutics
01/2022 - 07/2002
11Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 07/2006
11Hematopoietic Stem Cell Transplantation
01/2020 - 12/2004
9Adjuvant Chemotherapy
05/2021 - 10/2004
6Transplantation
08/2016 - 04/2002
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2021 - 04/2002
5Stem Cell Transplantation
12/2020 - 08/2005
5Combination Drug Therapy (Combination Chemotherapy)
06/2013 - 11/2009
4Chemoradiotherapy
12/2017 - 04/2010
4Radiotherapy
01/2017 - 01/2007